Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 20, 2025 • 10:40 AM ET

Date/Time Source News Release
11/13/2023 08:05 AM EST GlobeNewswire Selecta Biosciences Announces Merger with Cartesian Therapeutics
10/31/2023 04:03 PM EDT GlobeNewswire Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
08/17/2023 07:00 AM EDT GlobeNewswire Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics
05/31/2023 07:00 AM EDT GlobeNewswire Selecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of Rheumatology
05/04/2023 07:30 AM EDT GlobeNewswire Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
04/28/2023 04:05 PM EDT GlobeNewswire Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update
03/21/2023 03:30 AM EDT GlobeNewswire Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint
03/02/2023 07:30 AM EST GlobeNewswire Selecta Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
02/23/2023 08:00 AM EST GlobeNewswire Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Update
02/07/2023 08:00 AM EST GlobeNewswire Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference
Page

Additional News

As of January 20, 2025 • 10:40 AM ET

Date/Time Source News Release
11/13/2023 08:41 AM EST SeekingAlpha Selecta merges with Cartesian Therapeutics in all-stock deal
11/09/2023 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, November 9th, 2023
11/09/2023 04:54 AM EST US Earnings Reports Expected earnings - Selecta Biosciences Inc.
11/03/2023 06:17 AM EDT US Earnings Reports Expected earnings - Selecta Biosciences Inc.
11/01/2023 08:51 AM EDT SeekingAlpha BYU, WE and IRIX among pre-market losers
10/25/2023 05:46 PM EDT SeekingAlpha Selecta Biosciences files for $200M mixed shelf
09/18/2023 01:21 PM EDT Zacks CHMP Endorses BioMarin's (BMRN) Voxzogo for Use in Infants
09/18/2023 11:39 AM EDT Zacks CHMP Endorses AstraZeneca's (AZN) Enhertu in Lung Cancer
08/17/2023 08:15 AM EDT Zacks Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimates
08/17/2023 07:58 AM EDT SeekingAlpha Selecta Biosciences GAAP EPS of -$0.07 beats by $0.01, revenue of $5.2M misses by $5.89M
Page